Scientists generate promising new model for predicting how individual lung tumours will respond to different drugs

February 23, 2010, Vancouver, B.C. - Scientists at the BC Cancer Agency and Vancouver Coastal Health Research Institute have generated a promising new method that may one day aid oncologists in the faster identification of which chemotherapy regimens may be useful for treating a particular patient’s non-small cell lung cancer (NSCLC) and which are unlikely to be effective. The results of their...

BC Cancer Agency scientists unlock clues to lymphoma

Researchers at BC Cancer Agency identify one of the most frequently mutated single genes in the fastest growing cancer in North America
January 18, 2010, Vancouver, B.C. - Scientists from the BC Cancer Agency have discovered a never before seen DNA spelling mistake, or mutation, in a gene called EZH2 in diffuse large B-cell lymphoma and follicular lymphoma, the two most common types of non-Hodgkins lymphoma. This groundbreaking discovery, which was published online on January 17 in the prestigious international science journal...

Research to help patients whose cancers resist therapy

The B.C. Government and the BC Cancer Foundation announced Dr. François Bénard as the B.C. Leadership Chair in Functional Cancer Imaging. He will lead the development of novel radiopharmaceuticals that zero in on tumours too small to be found otherwise. They will also enable clinicians to see quickly whether a cancer is responding to treatment.